Imricor Medical Systems Inc - Asset Resilience Ratio

Latest as of March 2018: 62.21%

Imricor Medical Systems Inc (IMR) has an Asset Resilience Ratio of 62.21% as of March 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Imricor Medical Systems Inc debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

AU$3.54 Million
≈ $2.50 Million USD Cash + Short-term Investments

Total Assets

AU$5.69 Million
≈ $4.02 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2023–2023)

This chart shows how Imricor Medical Systems Inc's Asset Resilience Ratio has changed over time. See Imricor Medical Systems Inc (IMR) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Imricor Medical Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Imricor Medical Systems Inc stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$3.54 Million 62.21%
Total Liquid Assets AU$3.54 Million 62.21%

Asset Resilience Insights

  • Very High Liquidity: Imricor Medical Systems Inc maintains exceptional liquid asset reserves at 62.21% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Imricor Medical Systems Inc Industry Peers by Asset Resilience Ratio

Compare Imricor Medical Systems Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Vitrolife AB
ST:VITR
Medical Devices 7.27%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Tellgen Corp
SHE:300642
Medical Devices 8.60%
Lumos Diagnostics Holdings Ltd
AU:LDX
Medical Devices 9.40%
T&R Biofab Co. Ltd
KQ:246710
Medical Devices 0.12%
Ok Biotech Co Ltd
TW:4155
Medical Devices 0.32%
Promimic AB
ST:PRO
Medical Devices 8.62%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

Annual Asset Resilience Ratio for Imricor Medical Systems Inc (2023–2023)

The table below shows the annual Asset Resilience Ratio data for Imricor Medical Systems Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -4.66% AU$-387.09K
≈ $-273.89K
AU$8.31 Million
≈ $5.88 Million
--
pp = percentage points

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices
Market Cap
$425.79 Million
AU$601.78 Million AUD
Market Cap Rank
#13391 Global
#340 in Australia
Share Price
AU$1.88
Change (1 day)
-2.34%
52-Week Range
AU$1.20 - AU$2.20
All Time High
AU$2.79
About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include… Read more